morning sickness

ACOG Guidelines at a Glance: Nausea and Vomiting of PregnancyThis common condition of pregnancy has potential for costly medical management and significant psychosocial and medical morbidity.
Diclectin effective for nausea and vomiting of pregnancy (VIDEO)Pregnant women experiencing morning sickness may gain relief from Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride.
New molecular entity
New molecular entityIn April 2013, FDA approved doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg (Diclegis, Duchesnay) for the treatment of nausea and vomiting in pregnant women who do not respond to conservative management. Diclegis is a delayed-release formulation combining 10 mg of the antihistamine doxylamine succinate and 10 mg of the vitamin B6 analog pyridoxine hydrochloride. This combination was once marketed in the United States as Bendectin. However, legal suits claiming related birth defects forced the manufacturer to withdraw Bendectin from the market in the 1980s. Doxylamine/pyridoxine has not been studied in women with hyperemesis gravidarum.
FDA approves Diclegis for treatment of morning sickness
FDA approves Diclegis for treatment of morning sickness
FDA approves Diclegis for treatment of morning sicknessFDA has approved doxylamine succinate 10 mg, pyridoxine hydrochloride 10 mg (Diclegis, Duchesnay) delayed-release tablets for the treatment of nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management, including dietary and lifestyle modifications. These modifications include eating several small meals instead of 3 large meals, eating bland foods that are low in fat and easy to digest, and avoiding smells that can trigger nausea.
FDA approves Diclegis for treatment of morning sicknessFirst new NVP approval in 50 years brings back 30-year-old drug